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Case Report
Anaphylactic Reaction after Intramuscular Injection of Cyanocobalamin (Vitamin
B12): a Case Report
Fareena Bilwani, Salman N. Adil, Usman Sheikh, Ayesha Humera, Mohammad Khurshid
Department of Pathology, The Aga Khan University Hospital, Karachi.

Abstract
We report a case of anaphylactic reaction to intramuscular injection of cyanocobalamin. This 52-year-old
lady was diagnosed as a case of megaloblastic anemia secondary to dietary vitamin B12 deficiency. She had severe
anaphylactic reaction after the parenteral administration of
cyanocobalamine. Later she received oral vitamin B12 with
no adverse effects.
The purpose of this case report is to draw attention to
the hypersensitive reaction to injectable vitamin B12, which
is rarely seen. This could be due to sensitization to the vitamin B12 molecule itself or an IgE mediated reaction.

We concluded that anaphylactic reaction to vitamin
B12 is a rare but serious side effect and it should be kept in
mind while the drug is being administered to the patient,
especially via the parenteral route.

Introduction
Vitamin B12 is commonly used in the management
of megaloblastic anemia, which is mostly caused by deficiency of vitamin B 12 or folic acid. Both oral and parenteral preparations of vitamin B 12 are available. Most physicians generally use parenteral form of therapy. A typical
treatment schedule consists of 1000µg cobalamin administered intramuscularly daily for two weeks, then

weekly until the hemoglobin and hematocrit is normal and
then monthly for life.1 We present a case of anaphylactic
reaction secondary to intramuscular injection of
cyanocobalamin in a female patient diagnosed to have
megaloblastic anemia due to vitamin B12 deficiency.

Case Report
A 52-year-old female presented in the hematology
outpatient with history of weakness for six months. Her past
medical and surgical history was unremarkable. Her personal history revealed that her diet consisted mainly of vegetables and there was hardly any intake of meat or dairy products. She gave no history of any drug intake. General examination revealed pallor, while rest of the general and systemic examination was unremarkable.
Her complete blood count showed hemoglobin:
6.5gm/dl, MCV: 102 fl, white cell count: 8,500/cumm and
platelets: 302,000/cumm. Her reticulocyte count was 0.6%.
Peripheral blood film revealed macrocytes along with right
shift neutrophils. Bone marrow aspirate was consistent with
megaloblastic anemia. Her serum B12 and red cell folate
levels were found to be 39.9 pg/ml (normal range: 200-950)
and 188.2 ng/ml (normal range: 175-700) respectively. A
diagnosis of megaloblastic anemia secondary to vitamin
B12 deficiency was made. Her serum intrinsic factor antibody was found to be negative. Schilling's was not done as
this is not available in Pakistan.
She was offered both oral and injectable forms of
vitamin B12. She preferred intramuscular injection of vitamin B12, therefore, therapy with injection cyanocobalamin
1000 mcg intramuscularly was started.. No adverse effects
were observed after receiving three injections on alternate
days. Her hemoglobin levels also improved and after a week
it was 8.9gm/dl. After a week fourth dose was given with no
complaints.
She developed generalized urticaria with pruritis,
shivering, nausea, vomiting, abdominal cramps, swelling on
tongue and bronchospasm after five minutes of receiving
her fifth dose the next week.Her vitals revealed blood pressure of 70/50 mmHg, pulse 110/min and respiratory rate
was 32 /min. On auscultation of chest there was bilateral
wheeze. She was immediately given epinephrine subcutaneously with intravenous hydrocortisone and antihistamines
which relieved her signs and symptoms. Then she was
offered oral cyanocobalamin and no adverse event was
reported. We document an anaphylactic reaction in our
patient secondary to an intramuscular injection of
cyanocobalamin.

Discussion
The purpose of this case report is to draw attention to
the possibility, though rare, of hypersensitive reaction to

injectable forms of vitamin B12. Only a few case reports
have been published regarding the anaphylactic reaction
due to injection of vitamin B 12 and none have been reported from our part of the world.
There are four forms of cobalamin - cyanocobalamin, hydroxycobalamin and two coenzyme forms i.e.
methylcobalamin and adenosylcobalamin.2 The reported
hypersensitivity reactions to vitamin B12 range from
urticaria and other skin rashes to severe anaphylactic reactions leading to circulatory collapse and even death.3
Published literature suggests that allergic reactions
to vitamin B12 can be either due to the preservatives added
in the injectable form or due to the molecule of the vitamin
itself. Lagerho et al reported a case of hypersensitivity to
benzyl alcohol added as preservative in vitamin B 12 injections resulting in urticaria.5 Patients have also reacted to
specially prepared highly purified hydroxycobalamin and
other cobalamins, which might suggest that patients were
sensitized to the vitamin B12 molecule itself.4 Further
research would decide whether a polypeptide bound to the
vitamin or a carry-over polypeptide is the antigen present in
such cases.
Another proposed mechanism of anaphylactoid reaction to intramuscular hydroxycobolamin is said to be Ig E
mediated reaction.6 This was demonstrated by in-vitro
release of histamine by basophils in patients receiving
hydroxycobalamin. It was however, noted that IgE mediated reaction is not seen with the administration of
cyanocobalamin.
Apart from the injectable forms of the vitamin B12,
hypersensitivity reaction has been reported in patients given
the drug orally.7 Marmite is a dark brown colored food item
extracted from yeast which is at times fortified with vitamins. There is a report of sensitized patient reacting to
Marmite fortified with cyanocobalamin.3
In our patient the anaphylactic reaction occurred
after the intramuscular injection of fifth dose of cyanocobalamin whereas, there was no reaction to the first four injections and she also tolerated the oral form of cyanocobalamin
well. In the published literature, one case of anaphylactic
reaction after the third dose of intramuscular cyanocobalamin is reported and later this patient with pernicious anemia was given oral vitamin B12 with no adverse reactions.4
In another case report, a patient with pernicious anemia was
treated with intramuscular cyanocobalamin for eight years;
it was given to her again after eight years. She experienced
an anaphylactic reaction.7 Later this patient was also
changed to the oral route. The authors in both these reports,
however, were skeptical to the oral vitamin B12 in patients
with pernicious anemia.

The reason for the absence of any adverse reaction in
the initial doses could not be explained in these case reports.
The assumption for tolerating the oral preparation could be
the presence of substances used as preservative in injectable
form of this vitamin.4 However, further explanation is
required in this regard.
We concluded that anaphylactic reaction to vitamin
B12 is a rare but serious side effect and it should be kept in
mind while the drug is being administered to the patient,
especially via the parental route.
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